Decitabine Versus Azacitidine in Myelodysplastic Syndrome Patients With Low and Intermediate-1 Risk
Clinical trial NCT01720225 · COMPLETED
Trial details
- NCT number
- NCT01720225
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-06
- Primary completion
- 2020-01-08
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.